Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.65 |
| ▸ | TOP2A | P11388 | 6/20 | 0.52 |
| ▸ | TOP2B | Q02880 | 6/20 | 0.52 |
| ▸ | STAT3 | P40763 | 1/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7011806 | 0.93 | ADRB2 (0.59) | ADRB2TOP2ATOP2BSTAT3KCNH2 | |
| SCHEMBL9188190 | 0.93 | ADRB2 (0.61) | ADRB2TOP2ATOP2BSTAT3KCNH2 | |
| SCHEMBL10627001 | 0.92 | ADRB2 (0.66) | ADRB2TOP2ATOP2BSTAT3KCNH2 | |
| SCHEMBL29492858 | 0.92 | ADRB2 (0.68) | ADRB2TOP2ATOP2BSTAT3KCNH2 | |
| SCHEMBL2844967 | 0.92 | ADRB2 (0.68) | ADRB2TOP2ATOP2BSTAT3KCNH2 | |
| SCHEMBL7584091 | 0.91 | ADRB2 (0.57) | ADRB2TOP2ATOP2BSTAT3KCNH2 | |
| SCHEMBL7005951 | 0.91 | ADRB2 (0.57) | ADRB2TOP2ATOP2BSTAT3KCNH2 | |
| SCHEMBL7006273 | 0.90 | ADRB2 (0.56) | ADRB2TOP2ATOP2BSTAT3KCNH2 | |
| SCHEMBL30944930 | 0.90 | ADRB2 (0.56) | ADRB2TOP2ATOP2BSTAT3KCNH2 | |
| SCHEMBL7011678 | 0.90 | ADRB2 (0.56) | ADRB2TOP2ATOP2BSTAT3KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020049223-A1 | Quinoline and naphthyridine carboxylic acid antibacterials | ABBOTT LABORATORIES | 2002-04-25 | — | — | US | disclosed |
| US-5169853-A | Antibacterial agents; administering to mammals for infection | STERLING DRUG INC. (US) | 1992-12-08 | — | — | US | disclosed |
| US-5075319-A | Bactericides | STERLING DRUG INC. (US) | 1991-12-24 | — | — | US | disclosed |
| EP-0417669-A2 | Pyridinyl-quinolone compounds, their preparation and use | STERLING WINTHROP INC. (US) | 1991-03-20 | — | — | EP | disclosed |
| EP-0309789-A1 | 4-Oxo-3-quinolinecarboxylic acids useful as antibacterial agents and preparation thereof | STERLING WINTHROP INC. (US) | 1989-04-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020049223-A1 | Quinoline and naphthyridine carboxylic acid antibacterials | NQO2, NQO1, NDUFA7 | ADRB2 3198/4885TOP2A 182/4885TOP2B 434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.